Menopause Relief
Natural health product licensed in Canada
- Licence holder
- Celex Laboratories Inc.
- NPN or DIN-HM
- 80090382
- Status
- Active licence
- Licence date
- 30 January 2019
- Revision date
- 30 August 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Thiamine Source : Mononitrate de thiamine | 25 mg | Not calculated |
| Fer Source : Gluconate de fer (II) | 15 mg | Not calculated |
| Niacine Source : Niacinamide | 25 mg | Not calculated |
| Extrait d'isoflavones de trèfle rouge Source : Trifolium pratense - sommité (herbe) Potency : 4 % Daidzein | 300 mg | Not calculated |
| Extrait d'isoflavones de trèfle rouge Source : Trifolium pratense - sommité (herbe) Potency : 4 % Genistein | 24 EAI | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Hydroxypropylméthylcellulose, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes ménopausées et en postménopause | minimum: 19 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in the maintenance of good health. Helps to maintain the body's ability to metabolize nutrients. Source of/An antioxidant for the maintenance of good health. Helps to reduce tiredness and fatigue caused by iron deficiency anemia. May reduce severe and frequent menopausal symptoms (such as hot flashes/flushes and/or night sweats. Helps to attenuate/reduce bone mineral density (BMD) loss in post-menopausal women when used in conjunction with adequate amounts of calcium and vitamin D.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
If you experience breast pain, discomfort, soreness and/or tenderness, abnormal uterine bleeding including spotting and/or recurrence of menstruation in postmenopausal women, discontinue use and consult a health care practitioner. Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness.
- Contre-indications
Do not use if you are pregnant, breastfeeding or attempting to conceive unless you have consulted with a health care practitioner/health care provider/health care professional/doctor/physician. If you have allergy/hypersensitivity to members of the Apiaceae/Umbelliferae family (anise, caraway, carrot, celery, dill, parsley), do not use this product. If you have hypermenorrhoea/profuse menstrual flow/heavy periods, do not use this product. If you currently have or previously had breast cancer or if you have a predisposition to breast cancer, as indicated by an abnormal mammogram and/or biopsy, or if you have a family member with breast cancer, do not use this product.
- Précautions et mises en garde
Keep out of reach of children. There is enough iron in this package to seriously harm a child. Hypersensitivity has been known to occur; in which case, discontinue use. Consult a health care practitioner if symptoms persist and or worsen. Consult a health care practitioner prior to use if you are breastfeeding. Consult a health care practitioner prior to use if you have a liver disorder or develop symptoms of liver trouble. If you are taking blood thinners/ anticoagulants, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are taking hormone-containing medications such as progesterone preparations, oral contraceptives or hormone replacement therapy. If you have cancer, consult a healthcare practitioner prior to use. If menstruation is delayed or absent, or if you experience increased menstrual bleeding time, discontinue use and consult a health care practitioner. Consult a health care practitioner prior to use if you have depression and/or related diseases. If you have a history of hormonal or gynecological disease including ovarian cancer, endometriosis and/or uterine fibroids, consult a health care practitioner prior to use. Ensure that you are up-to-date on appointed clinical tests such as mammograms and endometrial ultrasounds or biopsies before using this product. If you have diarrhoea or haemorrhagic diseass, do not use this product. Consumption of Hops with alcohol, other medications and /or natural Health products with sedative properties is not recommended.
Source
Official Health Canada record, licence 80090382
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging